Homrich & Berg’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $1.06M | Sell |
9,325
-20
| -0.2% | -$2.27K | 0.02% | 214 |
|
|
2021
Q2 | $968K | Buy |
9,345
+3,847
| +70% | +$398K | 0.02% | 217 |
|
|
2021
Q1 | $460K | Buy |
5,498
+285
| +5% | +$23.8K | 0.01% | 283 |
|
|
2020
Q4 | $476K | Buy |
5,213
+447
| +9% | +$40.8K | 0.01% | 276 |
|
|
2020
Q3 | $380K | Sell |
4,766
-244
| -5% | -$19.5K | 0.01% | 243 |
|
|
2020
Q2 | $346K | Buy |
5,010
+285
| +6% | +$19.7K | 0.01% | 241 |
|
|
2020
Q1 | $297K | Sell |
4,725
-135
| -3% | -$8.49K | 0.02% | 234 |
|
|
2019
Q4 | $378K | Buy |
4,860
+30
| +0.6% | +$2.33K | 0.02% | 263 |
|
|
2019
Q3 | $354K | Sell |
4,830
-231
| -5% | -$16.9K | 0.02% | 256 |
|
|
2019
Q2 | $312K | Buy |
5,061
+78
| +2% | +$4.81K | 0.02% | 278 |
|
|
2019
Q1 | $318K | Buy |
+4,983
| New | +$318K | 0.02% | 260 |
|
|
2018
Q4 | – | Sell |
-3,606
| Closed | -$209K | – | 308 |
|
|
2018
Q3 | $209K | Buy |
+3,606
| New | +$209K | 0.01% | 308 |
|
|
2017
Q2 | – | Sell |
-32,892
| Closed | -$1.03M | – | 294 |
|
|
2017
Q1 | $1.03M | Sell |
32,892
-240
| -0.7% | -$7.52K | 0.09% | 94 |
|
|
2016
Q4 | $1.04M | Buy |
33,132
+201
| +0.6% | +$6.28K | 0.09% | 79 |
|
|
2016
Q3 | $1.32M | Sell |
32,931
-1,101
| -3% | -$44.2K | 0.12% | 61 |
|
|
2016
Q2 | $1.13M | Buy |
+34,032
| New | +$1.13M | 0.11% | 68 |
|
|
2015
Q2 | – | Sell |
-9,210
| Closed | -$219K | – | 261 |
|
|
2015
Q1 | $219K | Buy |
+9,210
| New | +$219K | 0.02% | 229 |
|